RecruitingNot ApplicableNCT06542224

Identifying Local Field Potential Biomarkers for Obsessive-compulsive Disorder Treatment With Deep Brain Stimulation


Sponsor

West China Hospital

Enrollment

16 participants

Start Date

Aug 3, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

Obsessive-compulsive disorder (OCD) is a complex and severe mental illness characterized by multiple symptoms and is considered a leading cause of non-fatal health loss. However, nearly 20% of patients do not respond to standard pharmacological or psychological treatments. Currently, we lack objective brain-based biomarkers. To address this issue, we used a novel device for electrophysiology recording and applied deep brain stimulation (DBS) to 16 OCD patients. In this study, we aim to use long-term invasive neural signal collection and machine learning techniques to reveal the complex relationship between these signals and OCD symptoms. By applying advanced machine learning algorithms, our goal is to establish highly accurate prediction models to identify biomarkers associated with the occurrence and progression of OCD. The research will focus on the spatiotemporal features of neural signals and build personalized OCD decoding models based on individual differences through the integration and analysis of large-scale data. By delving into the information contained in neural signals, we hope to provide academic and practical innovations for the development of personalized treatment approaches for OCD.


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This trial is studying brain signal patterns (called local field potentials) in people with severe, treatment-resistant obsessive-compulsive disorder (OCD) who are undergoing deep brain stimulation (DBS) surgery. DBS involves implanting electrodes deep in the brain to modulate abnormal circuits. Researchers hope to identify unique brain patterns that can help fine-tune DBS for better OCD treatment. **You may be eligible if...** - You are 18–65 years old with an OCD diagnosis - Your OCD has persisted for more than 3 years and significantly impairs your daily life (unable to work, go to school, or maintain relationships) - You have tried and failed at least 3 types of serotonin reuptake inhibitors (SRIs) at high doses for at least 12 weeks each, or had serious side effects from them - CBT therapy has been ineffective or you have repeatedly refused it - Your OCD severity score (Y-BOCS) is 25 or higher **You may NOT be eligible if...** - Your OCD is mild or responds to standard medications or therapy - You are unwilling to undergo DBS surgery - You have other psychiatric conditions that would complicate treatment Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREDeep Brain stimulation

All subjects will receive bilateral surgical implantation of DBS system.


Locations(4)

West CHina Hospital,Sichuan University

Chengdu, Sichuan, China

The First People's hospital of Longquanyi District

Chengdu, Sichuan, China

Zigong Fifth People's Hospital

Zigong, Sichuan, China

Zigong Fourth People's Hospital

Zigong, Sichuan, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06542224


Related Trials